R.G. Niederhoffer Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-14,900
Closed -$1.41M 40
2019
Q1
$1.41M Buy
+14,900
New +$1.3M 12.8% 2
2018
Q3
Sell
-16,400
Closed -$1.3M 45
2018
Q2
$1.3M Buy
16,400
+11,500
+235% +$955K 7.48% 2
2018
Q1
$437K Buy
+4,900
New +$470K 2.12% 19
2017
Q4
Sell
-3,000
Closed -$437K 28
2017
Q3
$437K Sell
3,000
-3,100
-51% -$422K 2.81% 17
2017
Q2
$792K Buy
+6,100
New +$747K 6.55% 8
2016
Q3
Sell
-3,800
Closed -$375K 43
2016
Q2
$375K Buy
+3,800
New +$393K 2.38% 17
2015
Q4
Sell
-18,500
Closed -$2M 24
2015
Q3
$2M Buy
+18,500
New +$2.3M 9.88% 2
2013
Q3
Sell
-4,200
Closed -$246K 52
2013
Q2
$246K Buy
+4,200
New +$253K 3.29% 17

Other funds holding CELG

R.G. Niederhoffer Capital Management's CELG Position: Q2 2019 in Review

R.G. Niederhoffer Capital Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 14,900 shares — an estimated $1.41M sold.

R.G. Niederhoffer Capital Management first reported a position in CELG in Q2 2013 and held it in 8 quarters. The position peaked at $2M in Q3 2015. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • R.G. Niederhoffer Capital Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • R.G. Niederhoffer Capital Management sold 14,900 Celgene Corp shares in Q2 2019, an estimated $1.41M.
  • R.G. Niederhoffer Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 8 quarters.
  • R.G. Niederhoffer Capital Management's Celgene Corp position peaked at $2M in Q3 2015.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on R.G. Niederhoffer Capital Management's 13F filing for Q2 2019, filed 6 Aug 2019.